Study ID: IXL-201-14-189
Study Title
- Multicenter Trial for Adults With Partial Seizures
Teva Identifier
- IXL-201-14-189
ClinicalTrials.gov Identifier
- NCT00034814
Study Status
- Completed
Trial Condition(s)
- Epilepsy
Interventions
- Drug: Talampanel | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 65 Years
Trial Duration
- 01/01/2002 - 01/01/2006
Phase
- Phase 2
Study Type
Interventional